問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Linkou Chang Gung Medical Foundation
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2021-10-01 - 2027-06-30
Condition/Disease
Test Drug
Participate Sites16Sites
Recruiting13Sites
Terminated3Sites
2026-06-01 - 2029-01-16
Participate Sites9Sites
Not yet recruiting9Sites
2025-10-01 - 2031-04-30
Participate Sites3Sites
Recruiting3Sites
2026-01-01 - 2030-12-31
Participate Sites5Sites
Recruiting5Sites
2021-12-15 - 2025-08-31
2019-10-30 - 2026-11-30
Participate Sites7Sites
Recruiting7Sites
2024-12-01 - 2027-11-30
Chronic Spontaneous Urticaria Who Remain Symptomatic Despite H1 Antihistamine Treatment (EMBARQ – CSU1)
injection
Participate Sites10Sites
Recruiting10Sites
2024-05-01 - 2028-12-22
2024-12-01 - 2028-12-31
p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma
tablet
2022-12-01 - 2024-09-09
全部
